Penn Medicine Provider
Gynecologic Oncology
Emily M. Ko, MD, MSCR
4.9
(252)
Accepting new patients
Sees patients age 18 and up
Penn Gynecologic Oncology Washington Square
View 1 additional location
Make an appointmentCall 800-789-7366

About me

  • Medical Director, Pennsylvania Hospital Abramson Cancer Center
  • Director, Gynecologic Oncology Populations Sciences Research Program
  • Director, REACH--Research Equity Center for Gynecologic Cancers and Health
  • Gynecologic Oncology Fellowship: Associate Program Director
  • Senior Fellow, Leonard Davis Institute for Health Economics
  • Associate Professor of Obstetrics and Gynecology at the Pennsylvania Hospital

Education and training

  • Medical School: University of Massachusetts
  • Residency: Massachusetts General Hospital/Brigham and Women’s Hospital
  • Fellowship: University of North Carolina Hospitals

What my patients think about me

Average Rating
4.9

252 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
excellent service
April 2025
5.0
5.0
attentive, understanding and efficient
April 2025
5.0
5.0
i felt like she was extremely thorough
March 2025
5.0
5.0
i cant say enough positive things about dr ko! she saved my life and continues to do so ! she understands medicine and the human condition

Insurance accepted

My Locations

Learn about location
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Ko is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Ko E, Funk MJ, Clark L, Brewster W Did GOG99 and Portec1 Change Clinical Practice in the United States? , Gynecol Oncol, 129(1):12-17: 2013

Smith AJB, Alvarez R, Heintz J, Haggerty A, Ko EM Disparities in biomarker testing in ovarian cancer: a real-world analysis. , Am J Obstet Gynecol, 228(1):98-100: 2023

Smith AJB, Mulugeta-Gordon L, Pena D, Kanter GP, Bekelman JE, Haggerty AE, Ko EM Prior authorization in gynecologic oncology: An analysis of clinical impact. , Gynecol Oncol, 167(3):519-522: 2022

Hicks-Courant K, Kanter GP, Schapira MM, Brensinger CM, Liu Q, Ko EM Intensity of end-of-life care for gynecologic cancer patients by primary oncologist specialty. , Int J Gynecol Cancer , 32(6):695-703: 2022

Bodurtha Smith AJ, Pena D, Ko E Insurance-Mediated Disparities in Gynecologic Oncology Care. , Obstet Gynecol, 139(2):305-312: 2022

Saris DH, Bodurtha Smith AJ, Brensinger C, Kim SH, Haggerty AF, Latif N, Cory L, Giuntoli RL, Morgan MA, Lin LL, Ko EM Disparities in Cancer-Specific and Overall Survival in Black Women with Endometrial Cancer: A Medicare-SEER Study. , Gynecol Oncol Report, 40:100922: 2022

Ko EM, Bekelman JE, Hicks-Courant K, Brensinger CM, Kanter GP Association of gynecologic oncology versus medical oncology specialty with survival, utilization, and spending for treatment of gynecologic cancers. , Gynecol Oncol, 164(2):295-30: 2022

Aviki EM, Schleicher SM, Boyd L, Liang M, Ko EM, Zanotti K, Moss H The oncology care model and the future of alternative payment models: A gynecologic oncology perspective. , Gynecol Oncol, 162(3):529-531: 2021

Latif N, Oh J, Brensinger C, Morgan M, Lin L, Cory L, Ko EM Lymphadenectomy is Associated with an Increased Risk of Postoperative Venous Thromboembolism in Early Stage Endometrial Cancer. , Gynecol Oncol, 161(1):130-134: 2021

Ko EM, Brensinger CM, Cory L, Giuntoli 2nd RL, Haggerty AF, Latif NA, Aviles D, Martin L, Morgan MA, Lin LL Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology. , Gynecol Oncol, 159(2):394-401: 2020